| Name | Cvs Pharmacy #01068 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 1653 Main St, Athol, Massachusetts 01331 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (978) 249-7928 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The new variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detected in England replicates more than two times faster than the earlier strains. This replication advantage promises to make it the dominant global variant very shortly. This finding comes from a startling preprint that appeared on the medRxiv* server in December 2020.
Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center at the University of Kentucky.
Murad, Inc. announced it has tripled the size of its product development department to meet escalating demand for support functions sparked by the growing pipeline of innovative products created when Jeff Murad, Vice President of Product Development for Murad, joined the development team.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.
The Wall Street Journal's Washington Wire reports that, based on these results, Republicans have some selling to do, and The Washington Post gets back to basics with a primer on Medicare, Medicaid and Social Security.
› Verified 5 days ago
| NPI Number | 1952400319 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY #01068 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1653 Main St, Athol, MA 01331 |
| Phone Number | 978-249-6715 |
News Archive
The new variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detected in England replicates more than two times faster than the earlier strains. This replication advantage promises to make it the dominant global variant very shortly. This finding comes from a startling preprint that appeared on the medRxiv* server in December 2020.
Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center at the University of Kentucky.
Murad, Inc. announced it has tripled the size of its product development department to meet escalating demand for support functions sparked by the growing pipeline of innovative products created when Jeff Murad, Vice President of Product Development for Murad, joined the development team.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.
The Wall Street Journal's Washington Wire reports that, based on these results, Republicans have some selling to do, and The Washington Post gets back to basics with a primer on Medicare, Medicaid and Social Security.
› Verified 5 days ago
News Archive
The new variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) detected in England replicates more than two times faster than the earlier strains. This replication advantage promises to make it the dominant global variant very shortly. This finding comes from a startling preprint that appeared on the medRxiv* server in December 2020.
Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Dr. Vivek Rangnekar, associate director of translational research for the Markey Cancer Center at the University of Kentucky.
Murad, Inc. announced it has tripled the size of its product development department to meet escalating demand for support functions sparked by the growing pipeline of innovative products created when Jeff Murad, Vice President of Product Development for Murad, joined the development team.
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy. This marketing authorization represents the first regulatory approval of REVLIMID in Japan.
The Wall Street Journal's Washington Wire reports that, based on these results, Republicans have some selling to do, and The Washington Post gets back to basics with a primer on Medicare, Medicaid and Social Security.
› Verified 5 days ago
Cvs Pharmacy #01068 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1653 Main St, Athol, Massachusetts 01331 Phone: (978) 249-7928 | |
Eye Center Optical, Inc. Type: Eyewear Supplier (Equipment, not the service) Location: 184 Market Dr, Athol, Massachusetts 01331 Phone: (978) 248-9834 | |
Walgreens #17173 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1640 S Main St, Athol, Massachusetts 01331 Phone: (978) 249-9132 |